Net profit of Beta Drugs declined 4.80% to Rs 8.52 crore in the quarter ended December 2025 as against Rs 8.95 crore during the previous quarter ended December 2024. Sales declined 1.16% to Rs 87.27 crore in the quarter ended December 2025 as against Rs 88.29 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 87.27 | 88.29 | -1 |
| OPM % | 19.47 | 20.90 | - |
| PBDT | 14.86 | 17.55 | -15 |
| PBT | 10.47 | 14.31 | -27 |
| NP | 8.52 | 8.95 | -5 |
Powered by Capital Market - Live News